Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Meg Mangin

Chronic Illness Recovery, USA

Title: A novel immunotherapy provides evidence of the bacterial etiology of chronic inflammation

Biography

Biography: Meg Mangin

Abstract

Chronic inflammation is a sign of immune system dysfunction and a probable cause is found in the ability of cell wall deficient bacteria to invade nucleated cells. These pathogens persist within cellular cytoplasm by using strategies to evade elimination, such as down-regulation of the vitamin D receptor (VDR), the nuclear receptor which regulates the immune system. Elevated calcitriol indicates the immune system recognizes the presence of parasitic pathogens and is attempting to combat them by increasing the production of calcitriol to transcribe antimicrobial peptides (AMPs). The result is chronic inflammation and persistent intracellular infection. The angiotensin receptor blocker Olmesartan medoxomil, when used at higher than anti-hypertensive doses, appears to be an agonistic VDR ligand which up-regulates the bacterially-inhibited VDR. This is evidenced by a significant reduction in calcitriol following Olmesartan administration. An increase in AMP transcription and thus, elimination of intracellular bacteria is evidenced by Herxheimer reactions.